Manufacturer record
Life Line Pharma 188/1: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Life Line Pharma 188/1 (Puducherry) were declared Not of Standard Quality between April 2026 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Life Line Pharma 188/1 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rosuvastatin with Fenofibrate Tablets | RDF-2504Mfg 2025-06 · Exp 2027-06 | MISBRANDED DRUG In the composition the label should be mentioned as Rosuvastatin and Fenofibrate tablets IP. But the label is mentioned as only Rosuvastatin and Fenofibrate tablets. Hence it is Misbranded drug as per section 17 of Drugs and Cosmetics Act 1940.Misbranded | State Lab, DCL, TelanganaState lab | Apr 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.